Therapeutic Myths in Solid Organ Transplantation Infectious Diseases

Overview

Journal Open Forum Infect Dis

Specialty Infectious Diseases

Date 2024 Jul 10

PMID 38983710

Authors

Kellie J Goodlet

Erin K McCreary

Michael D Nailor

Darina Barnes

Marissa M Brokhof

Sarah Bova

Evan Clemens

Beth Kelly

Alicia Lichvar

Dawn M Pluckrose

Bryant B Summers

Kristen R Szempruch

Stephanie Tchen

Affiliations

Soon will be listed here.

Abstract

Infection management in solid organ transplantation poses unique challenges, with a diverse array of potential pathogens and associated antimicrobial therapies. With limited high-quality randomized clinical trials to direct optimal care, therapeutic "myths" may propagate and contribute to suboptimal or excessive antimicrobial use. We discuss 6 therapeutic myths with particular relevance to solid organ transplantation and provide recommendations for infectious diseases clinicians involved in the care of this high-risk population.

References

Limaye A, Budde K, Humar A, Vincenti F, Kuypers D, Carroll R . Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients: A Randomized Clinical Trial. JAMA. 2023; 330(1):33-42. PMC: 10245286. DOI: 10.1001/jama.2023.9106. View

Hirsch H, Randhawa P . BK polyomavirus in solid organ transplantation-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019; 33(9):e13528. DOI: 10.1111/ctr.13528. View

Al Jurdi A, Gassen R, Borges T, Solhjou Z, Hullekes F, Lape I . Non-Invasive Monitoring for Rejection in Kidney Transplant Recipients After SARS-CoV-2 mRNA Vaccination. Front Immunol. 2022; 13:838985. PMC: 8913529. DOI: 10.3389/fimmu.2022.838985. View

Martin J, Dvorak C, Smee D, Matthews T, Verheyden J . 9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine: a new potent and selective antiherpes agent. J Med Chem. 1983; 26(5):759-61. DOI: 10.1021/jm00359a023. View

Krantz M, Stone Jr C, Abreo A, Phillips E . Oral challenge with trimethoprim-sulfamethoxazole in patients with "sulfa" antibiotic allergy. J Allergy Clin Immunol Pract. 2019; 8(2):757-760.e4. PMC: 6960372. DOI: 10.1016/j.jaip.2019.07.003. View

Urbancic K, Ierino F, Phillips E, Mount P, Mahony A, Trubiano J . Taking the challenge: A protocolized approach to optimize Pneumocystis pneumonia prophylaxis in renal transplant recipients. Am J Transplant. 2017; 18(2):462-466. PMC: 5790633. DOI: 10.1111/ajt.14498. View

Wadei H, Rule A, Lewin M, Mahale A, Khamash H, Schwab T . Kidney transplant function and histological clearance of virus following diagnosis of polyomavirus-associated nephropathy (PVAN). Am J Transplant. 2006; 6(5 Pt 1):1025-32. DOI: 10.1111/j.1600-6143.2006.01296.x. View

Gabardi S, Millen P, Hurwitz S, Martin S, Roberts K, Chandraker A . Atovaquone versus trimethoprim-sulfamethoxazole as Pneumocystis jirovecii pneumonia prophylaxis following renal transplantation. Clin Transplant. 2012; 26(3):E184-90. DOI: 10.1111/j.1399-0012.2012.01624.x. View

Zmarlicka M, Martin S, Cardwell S, Nailor M . Tolerability of low-dose sulfamethoxazole/trimethoprim for Pneumocystis jirovecii pneumonia prophylaxis in kidney transplant recipients. Prog Transplant. 2015; 25(3):210-6. DOI: 10.7182/pit2015153. View

10.

Vermeiren P, Aubert V, Sugamele R, Aubert J, Venetz J, Meylan P . Influenza vaccination and humoral alloimmunity in solid organ transplant recipients. Transpl Int. 2014; 27(9):903-8. DOI: 10.1111/tri.12345. View

11.

Knowles W, Pipkin P, Andrews N, Vyse A, Minor P, Brown D . Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J Med Virol. 2003; 71(1):115-23. DOI: 10.1002/jmv.10450. View

12.

Guggenheimer J, Mayher D, Eghtesad B . A survey of dental care protocols among US organ transplant centers. Clin Transplant. 2005; 19(1):15-8. DOI: 10.1111/j.1399-0012.2005.00251.x. View

13.

Scharringa S, Hoffman T, van Kessel D, Rijkers G . Vaccination and their importance for lung transplant recipients in a COVID-19 world. Expert Rev Clin Pharmacol. 2021; 14(11):1413-1425. DOI: 10.1080/17512433.2021.1961577. View

14.

Martinez-Selles M, Valerio-Minero M, Farinas M, Rodriguez-Abella H, Rodriguez M, de Alarcon A . Infective endocarditis in patients with solid organ transplantation. A nationwide descriptive study. Eur J Intern Med. 2021; 87:59-65. DOI: 10.1016/j.ejim.2021.02.017. View

15.

Ritchie B, Barreto J, Barreto E, Crow S, Dierkhising R, Jannetto P . Relationship of Ganciclovir Therapeutic Drug Monitoring with Clinical Efficacy and Patient Safety. Antimicrob Agents Chemother. 2019; 63(3). PMC: 6395929. DOI: 10.1128/AAC.01855-18. View

16.

Chen R, Li D, Wang J, Zhuang S, Wu H, Wu J . Prophylactic effect of low-dose trimethoprim-sulfamethoxazole for Pneumocystis jirovecii pneumonia in adult recipients of kidney transplantation: a real-world data study. Int J Infect Dis. 2022; 125:209-215. DOI: 10.1016/j.ijid.2022.10.004. View

17.

Kueht M, Kirk K, Lea A, Stevenson H, Fair J, Kathleen Gamilla-Crudo A . Donor-directed immunologic safety of COVID-19 vaccination in renal transplant recipients. Hum Immunol. 2022; 83(8-9):607-612. PMC: 9279300. DOI: 10.1016/j.humimm.2022.07.002. View

18.

Bohl D, Storch G, Ryschkewitsch C, Gaudreault-Keener M, Schnitzler M, Major E . Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. Am J Transplant. 2005; 5(9):2213-21. DOI: 10.1111/j.1600-6143.2005.01000.x. View

19.

Cordero E, Bulnes-Ramos A, Aguilar-Guisado M, Gonzalez Escribano F, Olivas I, Torre-Cisneros J . Effect of Influenza Vaccination Inducing Antibody Mediated Rejection in Solid Organ Transplant Recipients. Front Immunol. 2020; 11:1917. PMC: 7574595. DOI: 10.3389/fimmu.2020.01917. View

20.

Nicolle L, Gupta K, Bradley S, Colgan R, DeMuri G, Drekonja D . Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria: 2019 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2019; 68(10):e83-e110. DOI: 10.1093/cid/ciy1121. View